“Molecular Mechanisms of FDA-Approved Drugs for the Treatment of Alzheimer’s Disease: A Comprehensive Review”. Molecular Medicine Communications, vol. 5, no. 1, June 2025, pp. 17-28, https://doi.org/10.55627/mmc.005.01.01795.